表紙:婦人科用手術機器の世界市場-2023年~2030年
市場調査レポート
商品コード
1347966

婦人科用手術機器の世界市場-2023年~2030年

Global Gynecology Surgical Devices Market - 2023-2030


出版日
ページ情報
英文 186 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
婦人科用手術機器の世界市場-2023年~2030年
出版日: 2023年09月11日
発行: DataM Intelligence
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

婦人科用手術機器の世界市場は、2022年に87億米ドルに達し、2023-2030年の予測期間中にCAGR 6.5%で成長し、2030年には161億米ドルに達すると予測されています。

婦人科用手術機器には、キュレットやスクープ、子宮摘出器具、子宮拡張器、プローブ、外陰・尿道スプレッダー、膣鏡、筋腫スクリューやメスなどが含まれます。発売数の増加と各社の戦略の増加が市場成長の原動力になると予想されます。

北米地域が市場シェアで大きな位置を占めると予想されます。主要企業による発売数の増加や提携により、この地域が支配的な地位を占めると予想されます。子宮鏡検査分野が大きな市場シェアを占めています。同機器に関連した治療開始件数の増加により、同セグメントが主導的地位を占めると予想されます。

ダイナミクス

機器の発売数の増加が市場成長を加速させる見込み

製品発売数の増加と技術進歩の増加が市場成長の原動力となります。高度に進歩した製品の発売も市場の成長に寄与します。例えば、2022年11月01日、Medtronic plcの完全子会社であるインド・メドトロニック社は、子宮内異常(IUA)の安全かつ効果的な治療に使用される機械式子宮鏡組織除去システムであるTruClearシステムの発売を発表しました。

さらに、2023年6月6日、医療機器会社Ceek Women's Health社は、サイドウォールレトラクターとLEDライトを内蔵したNella Single-Use Vaginal Speculumを発売しました。ネラ単回使用膣鏡は、複数の機能を1つの使いやすい器具にまとめたユニークな製品です。このため、同装置の発売が市場成長の原動力になると期待されています。

婦人科手術の件数増加が市場成長を牽引する見込み

婦人科手術の件数増加が市場成長の原動力になると予想されます。子宮摘出手術件数の増加が市場成長の原動力になると予想されます。例えば、ミシガン大学のRegents of the University of Michiganによると、子宮摘出術は帝王切開に次いで米国で生殖年齢の女性に行われる2番目に多い手術です。米国では毎年40万件以上の子宮摘出術が行われており、その68%近くが子宮の異常出血、子宮筋腫、子宮内膜症などの良性疾患に対して行われています。

さらに、NHSイングランドによると、2021-22年にはコルポスコピーへの紹介が235,223件報告され、2020-21年(176,561件)から33.2%増加したと推定されています。紹介の67.7%はスクリーニング検査を契機としたもので、20.8%は子宮頸部異常の症状を抱えた女性が臨床的に指摘されたものと報告されています。このように、大腸内視鏡検査件数の増加も市場成長の原動力となっています。少数の婦人科用手術機器に関連する安全性の問題が市場成長の妨げになると予想されます。

手術器具の合併症には、感染症、腹壁血腫、術後尿閉などがあります。合成尿道中部スリング装着後の短期的な排尿機能不全は一般的です。さらに、器具に関連するコストは市場の成長に影響を与える可能性があります。装置のコストが高いため、患者に代替の選択肢やオプションが生まれます。さらに、製品の安全性を確保するための厳しい規制承認手続きが、市場の成長を抑制しています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 機器の発売数の増加
      • 主要企業が展開する戦略
    • 抑制要因
      • 一部の婦人科用手術機器に関連する安全性の問題および市場における代替品
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMIの見解

第6章 COVID-19分析

第7章 製品タイプ別

  • トロカール
  • 膣鏡
  • 子宮キュレット(掻爬器)
  • ハサミ
  • ニードルホルダー
  • ダイレーター(拡張器)
  • 子宮デプレッサー

第8章 エンドユーザー別

  • 病院
  • クリニック
  • 外来手術センター

第9章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第10章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第11章 企業プロファイル

  • Ethicon Inc.
    • 企業概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な動向
  • Cooper Companies Inc.
  • Medtronic
  • Hologic, Inc.
  • KARL STORZ SE & Co. KG,
  • Boston Scientific Corporation
  • Olympus Corporation
  • Stryker
  • SternMed GmbH.
  • Richard Wolf GmbH

第12章 付録

目次
Product Code: MD2219

Overview

Global Gynecology Surgical Devices Market reached US$ 8.7 billion in 2022 and is expected to reach US$ 16.1 billion by 2030, growing with a CAGR of 6.5% during the forecast period 2023-2030.

The range of gynecology surgery instruments includes curettes and scoops, hysterectomy instruments, uterine dilators, probes, vulva and urethral spreaders, vaginal speculums, and myoma screws and knives. The increase in the number of launches and increase in the strategies by the companies are expected to drive the market growth.

The North America region is expected to hold a significant position in the market share. The increase in the number of launches by the key companies and their collaborations are expected to hold the region in the dominant position. The hysteroscopy segment holds a significant market share. The increased number of treatment launches associated with the devices expected to hold the segment in the leading position.

Dynamics

Increased Number of Launches of the Devices are Expected to Accelerate the Market Growth

An increased number of product launches and an increase in technological advancements will drive market growth. The launches of highly advanced products also contribute to the growth of the market. For instance, on 01 November 2022, India Medtronic, a wholly owned subsidiary of Medtronic plc, stated the launch of the TruClear system, a mechanical hysteroscopic tissue removal system used for the safe and effective treatment of intrauterine abnormalities (IUA).

Additionally, on June 06, 2023, Ceek Women's Health, a medical device company, launched the Nella Single-Use Vaginal Speculum with Integrated Sidewall Retractors and LED Light. The Nella Single-Use vaginal speculum is a unique product that combines several features into one easy-to-use device. Thus, the launches of the devices are expected to drive the market growth.

Increase in the Gynecological Surgeries are Expected to Drive the Market Growth

Increase in the number of gynecological surgeries is expected to drive the market growth. The increase in the number of hysterectomy surgeries is expected to drive the market growth. For instance, according to the Regents of the University of Michigan, Hysterectomy is the second most common surgery performed on reproductive-age women in the U.S. after cesarean section. More than 400,000 hysterectomies are performed in the U.S. each year, with nearly 68 percent done for benign conditions that involve abnormal uterine bleeding, uterine fibroids, and endometriosis.

Additionally, according to NHS England, it is estimated that 235,223 referrals to colposcopy were reported in 2021-22, an increase of 33.2% from 2020-21 (176,561). 67.7% of referrals were reported as being triggered by a screening test, and 20.8% of referrals were clinically indicated as the women holding the symptoms of cervical abnormality. Thus, the increase in the number of coloscopy procedures is also involved in driving the market growth. Safety Issues Associated with Few Gynecology Surgical Devices are Expected to Hamper the Market Growth.

Some of the complications of the surgical devices are infection, abdominal wall hematoma, and postoperative urinary retention. Short-term voiding dysfunction after placement of a synthetic mid-urethral sling is common. Additionally, the cost associated with the devices can affect the market growth. High costs of the devices create alternative choices and options for the patients. Furthermore, stringent regulatory approval procedures to ensure product safety are restraining the market's growth.

Segment Analysis

The global gynecology surgical devices market is segmented based on product type, application, end-user, and region.

Hysteroscopy Segment Holds a Significant Position in the Market Share

The increased number of launches of hysteroscopy devices is holding the segment in the dominant market share. For instance, on September 30, 2021, Hologic, Inc., a global leader in women's health, has launched its expanded Omni suite, a comprehensive gynecological surgical offering designed to optimize diagnostic and operative hysteroscopy in Europe, Africa, and the Middle East (EMEA). The offering includes a versatile Omni 30° hysteroscope, the Omni Lok cervical seal and the Omni 5 French seal, which complement the company's existing portfolio of GYN surgical solutions and extend physicians' choices.

Additionally, on July 27, 2023, GenWorks, a healthcare solutions provider launched its mechanical hysteroscopic tissue removal system which uses a simple mechanical approach for removing intrauterine tissues. This is an effective solution that offers better access and improved outcomes. Thus, increase in the number of launches of the hysteroscopes are elevating the market growth.

Geographical Penetration

North America Holds the Largest Market Share in the Global Gynecology Surgical Devices Market

North America is expected to hold a significant market share. The increased number of company collaborations and launches of the products in the region are holding the region in the leading market share. For instance, on November 30, 2022, Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures launched the moresolution Power Morcellator, which is manufactured by TROKAMED GmbH and is available in the U.S. through a distribution agreement with Olympus America, Inc. The moresolution Morcellator is designed for advanced gynecologic procedures with large, calcified tissue specimens.

On August 12, 2021, Innovia Medical launched a single-use instrument product line called Cervical Rotating Biopsy Punch in the U.S. It supports urgently needed procedures like cancer diagnosis. Thus, the number of launches of the products in the region by the major players expands the growth of the region in the market share.

Competitive Landscape

The global gynecology surgical devices market is fragmented, with the presence of many local and international players. Ethicon Inc., Cooper Companies Inc., Medtronic, Hologic, Inc., KARL STORZ SE & Co. KG, Boston Scientific Corporation, Olympus Corporation, Stryker, SternMed GmbH., and Richard Wolf GmbH are the leading Companies with a significant market share.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global gynecological surgical devices market growth. The COVID-19 pandemic caused disruption in consultation for gynecological disease diagnoses such as abdominal diseases, uterine infections, and others. The delayed consultations have impacted the treatment processes and, thus, impacted the market growth.

The delay in manufacturing the surgical devices by the key companies and the stringent rules and regulations by the governments have impacted the market growth. Thus, COVID-19 has impacted the market growth negatively. Thus, this factor was anticipated to restrain the demand for gynecology surgical devices market and restrain the market growth.

By Product Type

  • Trocars
  • Vaginal Speculums
  • Uterine Curettes
  • Scissors
  • Needle Holders
  • Dilators
  • Uterine Depressors

By End-User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Why Purchase the Report?

  • To visualize the global gynecology surgical devices market segmentation based on product type, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of gynecology surgical devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global gynecology surgical devices market report would provide approximately 61 tables, 58 figures, and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by End-User
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increased number of launches of the devices
      • 4.1.1.2. Strategies developed by the major players
    • 4.1.2. Restraints
      • 4.1.2.1. Safety issues associated with some gynecology surgical devices and alternatives in the market
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Trocars *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Vaginal Speculums
  • 7.4. Uterine Curettes
  • 7.5. Scissors
  • 7.6. Needle Holders
  • 7.7. Dilators
  • 7.8. Uterine Depressors

8. By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Clinics
  • 8.4. Ambulatory Surgical Centers

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. UK
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Ethicon Inc. *
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Cooper Companies Inc.
  • 11.3. Medtronic
  • 11.4. Hologic, Inc.
  • 11.5. KARL STORZ SE & Co. KG,
  • 11.6. Boston Scientific Corporation
  • 11.7. Olympus Corporation
  • 11.8. Stryker
  • 11.9. SternMed GmbH.
  • 11.10. Richard Wolf GmbH

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us